Alexicacus, spirit of salt of the world which vulgarly prepared is call'd the spirit of salt, or the transcendent virtue of the true spirit of salt [[electronic resource] ] : long look'd for and now philosophically prepared and purified from all hurtful and corroding qualities far beyond any thing yet known to the world, being both safe and pleasant for the use of all men, women and children / / by Constantine Rhodocanaces |
Autore | Rhodokanakēs Kōnstantinos <1635-1689.> |
Edizione | [This seventh edition enlarged with testimonies, advertisements and rare medicaments.] |
Pubbl/distr/stampa | London, : Printed by W.G., MDCLXX [i.e. 1670] |
Descrizione fisica | [2], 24 p |
Soggetto topico |
Salt - Therapeutic use
Materia medica |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996384515303316 |
Rhodokanakēs Kōnstantinos <1635-1689.>
![]() |
||
London, : Printed by W.G., MDCLXX [i.e. 1670] | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Alexicacus, spirit of salt of the world, which vulgarly prepar'd is call'd spirit of salt, or, The transcendent virtue of the true spirit of salt long looked for [[electronic resource] ] : and now philosophically prepared and purified from all hurtfull or corroding qualities, far beyond any thing yet known to the world : being both safe and pleasant for the use of all men, women, and children / / by Constantine Rhodocanaces . |
Autore | Rhodokanakēs Kōnstantinos <1635-1689.> |
Edizione | [This third edition is enlarged with some extraordinary testimonies, advertisements, and rare medicaments.] |
Pubbl/distr/stampa | London, : Printed by R.D., 1664 |
Descrizione fisica | [4], 20 p |
Soggetto topico |
Salt - Therapeutic use
Materia medica |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996390947003316 |
Rhodokanakēs Kōnstantinos <1635-1689.>
![]() |
||
London, : Printed by R.D., 1664 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Alexicacvs spirit of salt of the vvorld, which vulgarly prepair'd is call'd the spirit of salt., or, The transcendent virtue of the true spirit of salt [[electronic resource] ] : long look'd for, and now philosophically prepared and purified from all hurtfull or coroding qualities, far beyond any thing yet known to the world : being both safe and pleasant for the use of all men, women, and children / / by Constantine Rhodocanaces |
Autore | Rhodokanakēs Kōnstantinos <1635-1689.> |
Edizione | [This fifth edition is enlarged with some new testimonies, advertisements and rare medicaments by His Majesties special direction and allowance.] |
Pubbl/distr/stampa | London, : Printed by I. R., In the year 1667 |
Descrizione fisica | [8], 27 p |
Soggetto topico |
Salt - Therapeutic use
Materia medica |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996389527403316 |
Rhodokanakēs Kōnstantinos <1635-1689.>
![]() |
||
London, : Printed by I. R., In the year 1667 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Analysis of drug impurities [[electronic resource] /] / edited by Richard J. Smith and Michael L. Webb |
Pubbl/distr/stampa | Oxford ; ; Ames, Iowa, : Blackwell, 2007 |
Descrizione fisica | 1 online resource (290 p.) |
Disciplina |
615.1901
615/.1901 |
Altri autori (Persone) |
SmithRichard J
WebbMichael L |
Collana | Analytical chemistry series |
Soggetto topico |
Drugs - Analysis
Materia medica |
Soggetto genere / forma | Electronic books. |
ISBN |
1-281-32024-2
9786611320249 0-470-98874-6 0-470-99422-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Analysis of Drug Impurities; Contents; Preface; List of contributors; 1 Organic impurities in drug substance: origin, control, and measurement; 1.1 Introduction; 1.2 Origin of impurities; 1.2.1 Process impurities; 1.2.2 Degradation impurities; 1.2.3 Contamination impurities; 1.2.4 Other impurities; 1.3 Control of drug substance impurities; 1.3.1 Control of residual solvents; 1.3.2 Control of synthetic impurities; 1.3.3 Control of impurities in biological and botanical products; 1.3.4 Purification processes; 1.3.5 Control of impurities from packaging; 1.3.6 Control of contamination impurities
1.3.7 Control of degradants on stability1.4 Measurement of drug substance impurities; 1.4.1 HPLC; 1.4.2 GC; 1.4.3 CE; 1.4.4 General considerations; 1.5 Conclusions; Disclaimer; References; 2 Organic impurities in drug products: origin, control and measurement; 2.1 Introduction; 2.2 Analytical methodology; 2.3 Drug-excipient compatibility experimental design; 2.4 Degradation mechanisms; 2.5 Excipients' role in drug product destabilisation; 2.6 Processing as a source of moisture; 2.7 Hydrolysis; 2.8 Oxidation; 2.9 Photolysis; 2.10 Impact of processing on photostability 2.11 Miscellaneous reactions2.12 Container-closure systems; References; 3 Stereochemical impurities; 3.1 Introduction; 3.2 Separation techniques: direct resolution; 3.2.1 HPLC using CSPs; 3.2.2 HPLC using chiral mobile-phase additives; 3.2.3 Capillary electrophoresis using chiral selectors; 3.2.4 Supercritical fluid chromatography using chiral stationary phases; 3.2.5 Gas chromatography using chiral stationary phases; 3.3 Separation techniques: indirect resolution; 3.4 Non-separation techniques; 3.4.1 Chiroptical spectroscopy; 3.4.2 Nuclear magnetic resonance spectroscopy; 3.5 Conclusions AcknowledgementsReferences; 4 Low-level measurement of potent toxins; 4.1 Introduction; 4.2 Classes of genotoxic impurity; 4.2.1 Alkylating agents; 4.2.2 Reactive amines; 4.2.3 Fused tricyclics; 4.2.4 Substituted purines and pyrimidines; 4.2.5 Hydroperoxides; 4.3 The analytical challenge of genetic; 4.4 Gas chromatography; 4.4.1 Sample introduction techniques; 4.4.2 Detectors; 4.5 High-performance liquid chromatography; 4.5.1 Separation modes; 4.5.2 Detection techniques; 4.6 Supercritical fluid chromatography; 4.7 Thin-layer chromatography; 4.8 Sample pre-concentration 4.8.1 Liquid-liquid extraction4.8.2 Solid-phase extraction; 4.8.3 Solid-phase microextraction; 4.8.4 Liquid-phase microextraction; 4.9 Other techniques; 4.9.1 Electrochemical measurements; 4.9.2 Derivatisation methods; 4.10 Adapting analytical methods from fields beyond pharmaceuticalsimpurities analysis; 4.10.1 Antineoplastic agents; 4.10.2 Other fields; 4.11 Validation of trace analytical methods; 4.11.1 Sensitivity; 4.11.2 Specificity; 4.11.3 Accuracy; 4.11.4 Solution stability; 4.11.5 Linearity and precision; 4.12 Conclusions; References; 5 A systematic approach to impurity identification 5.1 Introduction |
Record Nr. | UNINA-9910145261903321 |
Oxford ; ; Ames, Iowa, : Blackwell, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Analysis of drug impurities [[electronic resource] /] / edited by Richard J. Smith and Michael L. Webb |
Pubbl/distr/stampa | Oxford ; ; Ames, Iowa, : Blackwell, 2007 |
Descrizione fisica | 1 online resource (290 p.) |
Disciplina |
615.1901
615/.1901 |
Altri autori (Persone) |
SmithRichard J
WebbMichael L |
Collana | Analytical chemistry series |
Soggetto topico |
Drugs - Analysis
Materia medica |
ISBN |
1-281-32024-2
9786611320249 0-470-98874-6 0-470-99422-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Analysis of Drug Impurities; Contents; Preface; List of contributors; 1 Organic impurities in drug substance: origin, control, and measurement; 1.1 Introduction; 1.2 Origin of impurities; 1.2.1 Process impurities; 1.2.2 Degradation impurities; 1.2.3 Contamination impurities; 1.2.4 Other impurities; 1.3 Control of drug substance impurities; 1.3.1 Control of residual solvents; 1.3.2 Control of synthetic impurities; 1.3.3 Control of impurities in biological and botanical products; 1.3.4 Purification processes; 1.3.5 Control of impurities from packaging; 1.3.6 Control of contamination impurities
1.3.7 Control of degradants on stability1.4 Measurement of drug substance impurities; 1.4.1 HPLC; 1.4.2 GC; 1.4.3 CE; 1.4.4 General considerations; 1.5 Conclusions; Disclaimer; References; 2 Organic impurities in drug products: origin, control and measurement; 2.1 Introduction; 2.2 Analytical methodology; 2.3 Drug-excipient compatibility experimental design; 2.4 Degradation mechanisms; 2.5 Excipients' role in drug product destabilisation; 2.6 Processing as a source of moisture; 2.7 Hydrolysis; 2.8 Oxidation; 2.9 Photolysis; 2.10 Impact of processing on photostability 2.11 Miscellaneous reactions2.12 Container-closure systems; References; 3 Stereochemical impurities; 3.1 Introduction; 3.2 Separation techniques: direct resolution; 3.2.1 HPLC using CSPs; 3.2.2 HPLC using chiral mobile-phase additives; 3.2.3 Capillary electrophoresis using chiral selectors; 3.2.4 Supercritical fluid chromatography using chiral stationary phases; 3.2.5 Gas chromatography using chiral stationary phases; 3.3 Separation techniques: indirect resolution; 3.4 Non-separation techniques; 3.4.1 Chiroptical spectroscopy; 3.4.2 Nuclear magnetic resonance spectroscopy; 3.5 Conclusions AcknowledgementsReferences; 4 Low-level measurement of potent toxins; 4.1 Introduction; 4.2 Classes of genotoxic impurity; 4.2.1 Alkylating agents; 4.2.2 Reactive amines; 4.2.3 Fused tricyclics; 4.2.4 Substituted purines and pyrimidines; 4.2.5 Hydroperoxides; 4.3 The analytical challenge of genetic; 4.4 Gas chromatography; 4.4.1 Sample introduction techniques; 4.4.2 Detectors; 4.5 High-performance liquid chromatography; 4.5.1 Separation modes; 4.5.2 Detection techniques; 4.6 Supercritical fluid chromatography; 4.7 Thin-layer chromatography; 4.8 Sample pre-concentration 4.8.1 Liquid-liquid extraction4.8.2 Solid-phase extraction; 4.8.3 Solid-phase microextraction; 4.8.4 Liquid-phase microextraction; 4.9 Other techniques; 4.9.1 Electrochemical measurements; 4.9.2 Derivatisation methods; 4.10 Adapting analytical methods from fields beyond pharmaceuticalsimpurities analysis; 4.10.1 Antineoplastic agents; 4.10.2 Other fields; 4.11 Validation of trace analytical methods; 4.11.1 Sensitivity; 4.11.2 Specificity; 4.11.3 Accuracy; 4.11.4 Solution stability; 4.11.5 Linearity and precision; 4.12 Conclusions; References; 5 A systematic approach to impurity identification 5.1 Introduction |
Record Nr. | UNISA-996218619503316 |
Oxford ; ; Ames, Iowa, : Blackwell, 2007 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Analysis of drug impurities [[electronic resource] /] / edited by Richard J. Smith and Michael L. Webb |
Pubbl/distr/stampa | Oxford ; ; Ames, Iowa, : Blackwell, 2007 |
Descrizione fisica | 1 online resource (290 p.) |
Disciplina |
615.1901
615/.1901 |
Altri autori (Persone) |
SmithRichard J
WebbMichael L |
Collana | Analytical chemistry series |
Soggetto topico |
Drugs - Analysis
Materia medica |
ISBN |
1-281-32024-2
9786611320249 0-470-98874-6 0-470-99422-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Analysis of Drug Impurities; Contents; Preface; List of contributors; 1 Organic impurities in drug substance: origin, control, and measurement; 1.1 Introduction; 1.2 Origin of impurities; 1.2.1 Process impurities; 1.2.2 Degradation impurities; 1.2.3 Contamination impurities; 1.2.4 Other impurities; 1.3 Control of drug substance impurities; 1.3.1 Control of residual solvents; 1.3.2 Control of synthetic impurities; 1.3.3 Control of impurities in biological and botanical products; 1.3.4 Purification processes; 1.3.5 Control of impurities from packaging; 1.3.6 Control of contamination impurities
1.3.7 Control of degradants on stability1.4 Measurement of drug substance impurities; 1.4.1 HPLC; 1.4.2 GC; 1.4.3 CE; 1.4.4 General considerations; 1.5 Conclusions; Disclaimer; References; 2 Organic impurities in drug products: origin, control and measurement; 2.1 Introduction; 2.2 Analytical methodology; 2.3 Drug-excipient compatibility experimental design; 2.4 Degradation mechanisms; 2.5 Excipients' role in drug product destabilisation; 2.6 Processing as a source of moisture; 2.7 Hydrolysis; 2.8 Oxidation; 2.9 Photolysis; 2.10 Impact of processing on photostability 2.11 Miscellaneous reactions2.12 Container-closure systems; References; 3 Stereochemical impurities; 3.1 Introduction; 3.2 Separation techniques: direct resolution; 3.2.1 HPLC using CSPs; 3.2.2 HPLC using chiral mobile-phase additives; 3.2.3 Capillary electrophoresis using chiral selectors; 3.2.4 Supercritical fluid chromatography using chiral stationary phases; 3.2.5 Gas chromatography using chiral stationary phases; 3.3 Separation techniques: indirect resolution; 3.4 Non-separation techniques; 3.4.1 Chiroptical spectroscopy; 3.4.2 Nuclear magnetic resonance spectroscopy; 3.5 Conclusions AcknowledgementsReferences; 4 Low-level measurement of potent toxins; 4.1 Introduction; 4.2 Classes of genotoxic impurity; 4.2.1 Alkylating agents; 4.2.2 Reactive amines; 4.2.3 Fused tricyclics; 4.2.4 Substituted purines and pyrimidines; 4.2.5 Hydroperoxides; 4.3 The analytical challenge of genetic; 4.4 Gas chromatography; 4.4.1 Sample introduction techniques; 4.4.2 Detectors; 4.5 High-performance liquid chromatography; 4.5.1 Separation modes; 4.5.2 Detection techniques; 4.6 Supercritical fluid chromatography; 4.7 Thin-layer chromatography; 4.8 Sample pre-concentration 4.8.1 Liquid-liquid extraction4.8.2 Solid-phase extraction; 4.8.3 Solid-phase microextraction; 4.8.4 Liquid-phase microextraction; 4.9 Other techniques; 4.9.1 Electrochemical measurements; 4.9.2 Derivatisation methods; 4.10 Adapting analytical methods from fields beyond pharmaceuticalsimpurities analysis; 4.10.1 Antineoplastic agents; 4.10.2 Other fields; 4.11 Validation of trace analytical methods; 4.11.1 Sensitivity; 4.11.2 Specificity; 4.11.3 Accuracy; 4.11.4 Solution stability; 4.11.5 Linearity and precision; 4.12 Conclusions; References; 5 A systematic approach to impurity identification 5.1 Introduction |
Record Nr. | UNINA-9910830641003321 |
Oxford ; ; Ames, Iowa, : Blackwell, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Analysis of drug impurities [[electronic resource] /] / edited by Richard J. Smith and Michael L. Webb |
Pubbl/distr/stampa | Oxford ; ; Ames, Iowa, : Blackwell, 2007 |
Descrizione fisica | 1 online resource (290 p.) |
Disciplina |
615.1901
615/.1901 |
Altri autori (Persone) |
SmithRichard J
WebbMichael L |
Collana | Analytical chemistry series |
Soggetto topico |
Drugs - Analysis
Materia medica |
ISBN |
1-281-32024-2
9786611320249 0-470-98874-6 0-470-99422-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Analysis of Drug Impurities; Contents; Preface; List of contributors; 1 Organic impurities in drug substance: origin, control, and measurement; 1.1 Introduction; 1.2 Origin of impurities; 1.2.1 Process impurities; 1.2.2 Degradation impurities; 1.2.3 Contamination impurities; 1.2.4 Other impurities; 1.3 Control of drug substance impurities; 1.3.1 Control of residual solvents; 1.3.2 Control of synthetic impurities; 1.3.3 Control of impurities in biological and botanical products; 1.3.4 Purification processes; 1.3.5 Control of impurities from packaging; 1.3.6 Control of contamination impurities
1.3.7 Control of degradants on stability1.4 Measurement of drug substance impurities; 1.4.1 HPLC; 1.4.2 GC; 1.4.3 CE; 1.4.4 General considerations; 1.5 Conclusions; Disclaimer; References; 2 Organic impurities in drug products: origin, control and measurement; 2.1 Introduction; 2.2 Analytical methodology; 2.3 Drug-excipient compatibility experimental design; 2.4 Degradation mechanisms; 2.5 Excipients' role in drug product destabilisation; 2.6 Processing as a source of moisture; 2.7 Hydrolysis; 2.8 Oxidation; 2.9 Photolysis; 2.10 Impact of processing on photostability 2.11 Miscellaneous reactions2.12 Container-closure systems; References; 3 Stereochemical impurities; 3.1 Introduction; 3.2 Separation techniques: direct resolution; 3.2.1 HPLC using CSPs; 3.2.2 HPLC using chiral mobile-phase additives; 3.2.3 Capillary electrophoresis using chiral selectors; 3.2.4 Supercritical fluid chromatography using chiral stationary phases; 3.2.5 Gas chromatography using chiral stationary phases; 3.3 Separation techniques: indirect resolution; 3.4 Non-separation techniques; 3.4.1 Chiroptical spectroscopy; 3.4.2 Nuclear magnetic resonance spectroscopy; 3.5 Conclusions AcknowledgementsReferences; 4 Low-level measurement of potent toxins; 4.1 Introduction; 4.2 Classes of genotoxic impurity; 4.2.1 Alkylating agents; 4.2.2 Reactive amines; 4.2.3 Fused tricyclics; 4.2.4 Substituted purines and pyrimidines; 4.2.5 Hydroperoxides; 4.3 The analytical challenge of genetic; 4.4 Gas chromatography; 4.4.1 Sample introduction techniques; 4.4.2 Detectors; 4.5 High-performance liquid chromatography; 4.5.1 Separation modes; 4.5.2 Detection techniques; 4.6 Supercritical fluid chromatography; 4.7 Thin-layer chromatography; 4.8 Sample pre-concentration 4.8.1 Liquid-liquid extraction4.8.2 Solid-phase extraction; 4.8.3 Solid-phase microextraction; 4.8.4 Liquid-phase microextraction; 4.9 Other techniques; 4.9.1 Electrochemical measurements; 4.9.2 Derivatisation methods; 4.10 Adapting analytical methods from fields beyond pharmaceuticalsimpurities analysis; 4.10.1 Antineoplastic agents; 4.10.2 Other fields; 4.11 Validation of trace analytical methods; 4.11.1 Sensitivity; 4.11.2 Specificity; 4.11.3 Accuracy; 4.11.4 Solution stability; 4.11.5 Linearity and precision; 4.12 Conclusions; References; 5 A systematic approach to impurity identification 5.1 Introduction |
Record Nr. | UNINA-9910840949003321 |
Oxford ; ; Ames, Iowa, : Blackwell, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The art of curing diseases by expectation [[electronic resource] ] : with remarks on a supposed great case of apoplectick fits : also most useful observations on coughs, consumptions, stone, dropsies, fevers, and small pox : with a confutation of dispensatories, and other various discourses in physick / / by Gideon Harvey . |
Autore | Harvey Gideon <1640?-1700?> |
Pubbl/distr/stampa | London, : Printed for James Partridge ..., 1689 |
Descrizione fisica | [4], 224 p |
Soggetto topico |
Therapeutics
Materia medica |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996386980303316 |
Harvey Gideon <1640?-1700?>
![]() |
||
London, : Printed for James Partridge ..., 1689 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Blagrave's supplement or enlargement to Mr. Nich. Culpeppers English physitian [[electronic resource] ] : containing a description of the form, names, place, time, coelestial government, and virtues, all such medicinal plants as grow in England, and are omitted in his book, called, The English-physitian, and supplying the additional virtues of such plants wherein he is defective : also the description, kinds, names, place, time, nature, planetary regiment, temperature, and physical virtues of all such trees, herbs, roots, flowers, fruits, excrescencies of plants, gums, ceres, and condensate juices, as are found in any part of the world, and brought to be sold in our druggist and apothecaries shops, with their dangers and corrections / / by Joseph Blagrave ... ; to which is annexed, a new tract for the cure of wounds made by gun-shot or otherways, and remedies for the help of seamen troubled with the scurvy and other distempers . |
Autore | Blagrave Joseph <1610-1682.> |
Pubbl/distr/stampa | London, : Printed for Obadiah Blagrave ..., 1674 |
Descrizione fisica | [4], 237, [16], 46 p |
Altri autori (Persone) | CulpeperNicholas <1616-1654.> |
Soggetto topico |
Botany, Medical
Materia medica |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996384911703316 |
Blagrave Joseph <1610-1682.>
![]() |
||
London, : Printed for Obadiah Blagrave ..., 1674 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Blagrave's supplement; or, enlargement, to Mr. Nich. Culpeper's English physician [[electronic resource] ] : Containing a description of the form, names, place, time, celestial government, and virtues, all such medicinal plants as grow in England, and are omitted in his book, called The English-physician. And supplying the additional virtues of such plants wherein he is defective. Also with the virtues of all drugs as are found in any part of the world, and brought to be sold in our druggists and apothecaries shops, with their dangers and corrections. By Joseph Blagrave of Reading, student in physick and astrology |
Autore | Blagrave Joseph <1610-1682.> |
Edizione | [The second impression. To which is annexed, a new tract of chirurgery for the cure of wounds made by gun-shot, or otherways, and remedies for the help of seamen troubled with the scurvey, and other distempers usually accompanying them; exceeding useful in times of war and peace, fitted for the meanest capacity.] |
Pubbl/distr/stampa | London, : printed for Obadiah Blagrave, at the sign of the Bear iu [sic] St. Paul's Church Yard, near the Little North Door, 1677 |
Descrizione fisica | [4], 237, [17], 46, [2] p., plate |
Altri autori (Persone) | CulpeperNicholas <1616-1654.> |
Soggetto topico |
Botany, Medical
Materia medica |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996394184003316 |
Blagrave Joseph <1610-1682.>
![]() |
||
London, : printed for Obadiah Blagrave, at the sign of the Bear iu [sic] St. Paul's Church Yard, near the Little North Door, 1677 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|